⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Sign up freeSee the full rankingSign in with Google
← Back to the full ranking · All companies

Aflac AFL

United States Financial Services
6.7/10
AI Analyst score
113.72 USD
Last price at analysis date · analyst target 118.53 (+4.2%)
🛒 Where to buy AFLPartner brokers · US (NYSE/Nasdaq) · sample 200.00 € orderUS (NYSE/Nasdaq)
Meridian is paid by these brokers at no extra cost to you; this is not investment advice. Public fee schedules · commission and FX, taxes excluded · Compare all 22 brokers by real cost →
No partner-broker fees for this market yet · Broker cost comparison →
🟡 HOLD — Hold. The combination of reasonable valuation, high profitability, and a growing, well-covered dividend (payout 25.67%) makes it an attractive defensive position, although future growth will be more moderate.

Aflac is a US insurance company specializing in supplemental life and health insurance, with a strong presence in Japan and the United States, selling policies through agents and employers. Aflac presents solid financial health (ROE 16.91%) and excellent business quality (net margin 26.91%), with an attractive valuation (P/E 12.27). The 46.8% earnings growth is an outlier that will likely normalize, but the core business remains robust.

Financial health
6.7
Quality / Moat
8.1
Valuation
5.7
Growth
6.1
Dividend
6.2
Momentum
4.4
Risk & Context
7.7

Detailed metrics

Market and fundamental data as of the analysis date.

💵 Valuation
P/E12.27
Fwd P/E15.08
EV/EBITDA10.59
P/B1.88
P/S3.16
PEG1.18
Market cap57.01 B USD
Enterprise value64.25 B USD
🏰 Quality and moat
ROIC (approx.)10.0%
Gross margin50.89%
FCF conversion85%
Operating margin25.72%
📈 Profitability and margins
ROE16.91%
ROA3.13%
Net margin26.91%
FCF5.15 B USD
FCF yield9.04%
🏦 Solvency and liquidity
Total debt16.18 B USD
Net debt7.24 B USD
Cash8.94 B USD
EBITDA6.06 B USD
Net debt / EBITDA1.19
D/E53.37
Current ratio0.89
Quick ratio0.78
🚀 Growth
Revenue growth-1.00%
Earnings growth46.80%
EPS (TTM)9.27 USD
EPS (Fwd)7.54 USD
💰 Dividend and risk
Dividend yield2.15%
Payout25.7%
Beta0.58
Analyst consensusHold (15)
Target price118.53 USD
52-week range105.43 USD – 130.22 USD
⚠️ Main risk: Heavy exposure to Japan (a very significant portion of revenue) creates a structural currency risk: a prolonged depreciation of the yen against the dollar erodes reported earnings and shareholder value.
See the full analysis and compare with the rest of the ranking →

Full AI report

Generated automatically from the metrics, the macro context and the company's news.

Aflac is a US insurance company specializing in supplemental life and health insurance, with a strong presence in Japan and the United States, selling policies through agents and employers. Aflac presents solid financial health (ROE 16.91%) and excellent business quality (net margin 26.91%), with an attractive valuation (P/E 12.27). The 46.8% earnings growth is an outlier that will likely normalize, but the core business remains robust.

Score by category

CategoryScore
Financial health6.7
Quality / Moat8.1
Valuation5.7
Growth6.1
Dividend6.2
Momentum4.4
Risk & Context7.7

OVERALL SCORE: 6.7/10

Context and risks

Aflac generates a very significant portion of its revenue and profits in Japan. The divergence in monetary policies (ECB hiking, Fed leaning toward cuts) does not directly affect it, but the weakness of the yen against the dollar, in a rising-rate environment in the US, pressures the conversion of its yen-denominated earnings to dollars, a structural risk to its reported earnings.

News considered in the analysis

  • Globe Life's Health Premium Growth Strengthens 2026 Outlook — Noticia sobre un competidor directo (Globe Life); no aporta información nueva sobre Aflac.
  • 4 Insurance Stocks With Two Big Profit Engines Backing the Dividend — Listículo genérico sin información específica y accionable sobre Aflac.
  • Life Insurance Stocks Q2 Recap: Benchmarking Aflac (NYSE:AFL) — Recapitulación de resultados del sector sin datos nuevos que no estén ya en el precio.
  • Can MetLife's Group Benefits Segment Maintain Its Momentum? — Análisis de un competidor (MetLife); sin impacto directo en los fundamentales de Aflac.
  • Is Aflac (AFL) Fairly Valued Following Mixed Earnings And Another Dividend Increase? — Resultados mixtos y nuevo aumento de dividendo; refuerza la solidez del payout pero no cambia la tesis de inversión.

Verdict: Hold. The combination of reasonable valuation, high profitability, and a growing, well-covered dividend (payout 25.67%) makes it an attractive defensive position, although future growth will be more moderate.

Main risk: Heavy exposure to Japan (a very significant portion of revenue) creates a structural currency risk: a prolonged depreciation of the yen against the dollar erodes reported earnings and shareholder value.

Other Financial Services companies

Neighbours in the sector ranking, to compare without going back to the index.

See all 1,000+ companies in the index →

Automatically generated analysis from fundamental, market and news data. Not personalised financial advice — a research tool, not an individual recommendation. Past performance does not guarantee future results. Last update of this analysis: 2026-09-28. Legal notice, privacy & cookies.